Combination therapy of rituximab and mycophenolate mofetil in childhood lupus nephritis
Pediatric Nephrology Aug 09, 2017
Hogan J, et al. – An analysis was formulated to gauge the impact of combination therapy of rituximab and mycophenolate mofetil (MMF) in childhood lupus nephritis (LN). As per the observations, therapy with rituximab (RTX) + MMF combined with a rapid decrease in steroid appeared as an efficacious treatment for severe LN. However, it was associated with high rate of varicella–zoster virus (VZV) infection.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries